Tirzepatide | Dual GIP/GLP-1 agonist | Probechem Biochemicals

Chemical Structure : Tirzepatide

CAS No.: 2023788-19-2

Tirzepatide (LY3298176)

Catalog No.: PC-72629Not For Human Use, Lab Use Only.

Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, binds both receptor with high affinity (GIPR Ki=0.135; GLP-1R Ki=4.23 nM).

Packing	Price	Stock
5 mg	$278	In stock
10 mg	$428	In stock
25 mg	$728	In stock
50 mg		Get quote
100 mg		Get quote

Get Quotation Now

* Please select Quantity before adding items.

or Bulk Inquiry

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Biological Activity

Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, binds both receptor with high affinity (GIPR Ki=0.135; GLP-1R Ki=4.23 nM).

Tirzepatide (LY3298176) is comparable to native GIP for the GIPR and approximately 5-fold weaker than native GLP-1 for the GLP-1R.

Tirzepatide (LY3298176) potently stimulates cAMP accumulation by either receptor (GIPR EC50=0.0224 nM; GLP-1R EC50=0.934 nM) in signaling studies using cell lines with recombinantly expressed GIPR or GLP-1R.

Tirzepatide (LY3298176) is less potent than the selective GLP-1RA semaglutide (Cat. PC-73177) (GLP-1R Ki=1.97 nM; cAMP EC50=0.0571 nM), and has minimal activity on the closely related glucagon receptor.

Tirzepatide (LY3298176) can induce glucose-dependent insulin secretion in vitro and in vivo through either the GIPR or the GLP-1R.

Physicochemical Properties

M.Wt	4813.45
Formula	C225H348N48O68
Appearance	Solid
CAS No.
Storage	Solide Powder -20°C 12 Months; 4°C 6 Months	In Solvent -80°C 6 Months; -20°C 6 Months
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2

References

1. Frias JP, et al. Lancet. 2018 Nov 17;392(10160):2180-2193.

2. Frias JP, et al. Diabetes Obes Metab. 2020 Jun;22(6):938-946.

3. Coskun T, et al. Mol Metab. 2018 Dec;18:3-14.

Tirzepatide (LY3298176)

Biological Activity

Physicochemical Properties

References

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

Get Quote

* Indicates a Required FieldYour information is safe with us.